Patents by Inventor Eliahu Pewzner

Eliahu Pewzner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8980174
    Abstract: The device disclosed herein may be affixed over a transparent dressing overlying the catheter entry point, or may be used independent of such a dressing. The device may be affixed to the catheter insertion site using an adhesive or fastening band, or through other methods. Depending on context, the device may be used continuously or periodically, and may be affixed such that it is directly abutting a transparent dressing or directly adjacent to the skin surface, or it may be spaced a certain distance from the skin. If spaced from the skin, light may be directed from the light sources, either directly or indirectly through optical conduits. Preferably the light sources will be positioned such that light from the light sources overlaps at one or more areas on the skin, especially the catheter entry point.
    Type: Grant
    Filed: May 11, 2012
    Date of Patent: March 17, 2015
    Assignee: Bactriblue, Ltd.
    Inventors: Eyal Haytman, Assaf Deutsch, Eliahu Pewzner
  • Patent number: 8768425
    Abstract: Disclosed are methods and devices comprising an elongated probe for the in vivo detection of meconium in amniotic fluid held in an amniotic sac based on detecting the presence of Zinc-coproporphyrin I (ZnCP). ZnCP is excited at approximately 405 nm and emits characteristic fluorescence, centered at about 580 nm and less intensely at 630 nm.
    Type: Grant
    Filed: October 5, 2008
    Date of Patent: July 1, 2014
    Assignee: Tel Hashomer Medical Research Infrastructure and Services Ltd.
    Inventors: Genady Kostenich, Sol Kimel, Arie Orenstein, Reuben Achiron, Eliahu Pewzner
  • Publication number: 20130303972
    Abstract: The device disclosed herein may be affixed over a transparent dressing overlying the catheter entry point, or may be used independent of such a dressing. The device may be affixed to the catheter insertion site using an adhesive or fastening band, or through other methods. Depending on context, the device may be used continuously or periodically, and may be affixed such that it is directly abutting a transparent dressing or directly adjacent to the skin surface, or it may be spaced a certain distance from the skin. If spaced from the skin, light may be directed from the light sources, either directly or indirectly through optical conduits. Preferably the light sources will be positioned such that light from the light sources overlaps at one or more areas on the skin, especially the catheter entry point.
    Type: Application
    Filed: May 11, 2012
    Publication date: November 14, 2013
    Inventors: Eyal Haytman, Assaf Deutsch, Eliahu Pewzner
  • Patent number: 8574490
    Abstract: Methods and apparatus for preventing patient bloodstream infection by microorganisms during administration of various medications or fluids through IV lines. In particular, the invention reduces contamination of IV lines, connecters, stopcock valves, manifolds, ports, etc. by means of irradiation by violet and/or blue light. Each embodiment comprises a source of violet and/or blue light and an optical element optically coupled to that light source for shaping the radiation pattern of the light emitted by the light source. Preferably, a light-emitting diode or a laser diode that emits light in the desired wavelength can be used. The optical element, optically coupled to the light source, is embedded or installed in or attached to a component of an IV set, the emitted light being directed to a “point of entry” or any other stagnation point of an IV set.
    Type: Grant
    Filed: March 31, 2010
    Date of Patent: November 5, 2013
    Assignee: Bactriblue, Ltd.
    Inventors: Eyal Haytman, Assaf Deutsch, Eliahu Pewzner
  • Publication number: 20110085936
    Abstract: Methods and apparatus for preventing patient bloodstream infection by microorganisms during administration of various medications or fluids through IV lines. In particular, the invention reduces contamination of IV lines, connecters, stopcock valves, manifolds, ports, etc. by means of irradiation by violet and/or blue light. Each embodiment comprises a source of violet and/or blue light and an optical element optically coupled to that light source for shaping the radiation pattern of the light emitted by the light source. Preferably, a light-emitting diode or a laser diode that emits light in the desired wavelength can be used. The optical element, optically coupled to the light source, is embedded or installed in or attached to a component of an IV set, the emitted light being directed to a “point of entry” or any other stagnation point of an IV set.
    Type: Application
    Filed: March 31, 2010
    Publication date: April 14, 2011
    Inventors: Eyal Haytman, Assaf Deutsch, Eliahu Pewzner
  • Publication number: 20100324391
    Abstract: Disclosed are methods and devices comprising an elongated probe for the in vivo detection of meconium in amniotic fluid held in an amniotic sac based on detecting the presence of Zinc-coproporphyrin I (ZnCP). ZnCP is excited at approximately 405 nm and emits characteristic fluorescence, centered at about 580 nm and less intensely at 630 nm.
    Type: Application
    Filed: October 5, 2008
    Publication date: December 23, 2010
    Inventors: Genady Kostenich, Sol Kimel, Arie Orenstein, Reuben Achiron, Eliahu Pewzner
  • Patent number: 7313424
    Abstract: An apparatus, system and method are provided for diagnosing the degree of body metabolic emergency state. A non-vital organ with respect to the metabolic emergency state is first chosen. One or more tissue viability parameters including at least one of NADH and Flavoprotein (Fp) concentration are monitored in the non-vital organ, whereupon the degree of body metabolic emergency state may be determined based on the monitored tissue viability parameters.
    Type: Grant
    Filed: March 6, 2003
    Date of Patent: December 25, 2007
    Assignee: CritiSense Ltd.
    Inventors: Avraham Mayevsky, Eliahu Pewzner, Assaf Deutsch, Tamar Manor
  • Publication number: 20070179366
    Abstract: Apparatus for determining the oxygenation state of at least one tissue element, comprising: a) illumination means for illuminating said tissue element with an illuminating radiation at a predetermined wavelength via at least one illumination location with respect to said tissue element, said illuminating radiation being at a wavelength within the NADH excitation spectrum or the Fp excitation spectrum; b) radiation receiving means and detection means for measuring the intensity of the corresponding NADH fluorescence or Fp fluorescence emitted by the tissue element at at least two predetermined wavelengths within the range of wavelengths comprised within the corresponding fluorescence emission spectrum.
    Type: Application
    Filed: October 10, 2006
    Publication date: August 2, 2007
    Applicant: CRITISENSE LTD.
    Inventors: Eliahu Pewzner, Avraham Mayevsky
  • Patent number: 7130672
    Abstract: Apparatus for monitoring a plurality of tissue viability parameters of a tissue layer element, in which two different illumination sources are used via a common illumination element in contact with the tissue. One illumination source is used for monitoring blood flow rate and optionally flavoprotein concentration, and collection fibers are provided to receive the appropriate radiation from the tissue. The other illuminating radiation is used for monitoring any one of and preferably all of NADH, blood volume and blood oxygenation state of the tissue element, and collection fibers are provided to receive the appropriate radiation from the tissue. In one embodiment, the wavelengths of the two illumination sources are similar, and common collection fibers for the two illuminating radiations are used. In another embodiment, the respective collection fibers are distanced from the illumination point at different distances correlated to the ratio of the first and second illuminating wavelengths.
    Type: Grant
    Filed: September 25, 2001
    Date of Patent: October 31, 2006
    Assignee: Critisense Ltd.
    Inventors: Eliahu Pewzner, Avraham Mayevsky
  • Publication number: 20060161055
    Abstract: An optical probe, for acquiring measurements of material in a surface, the probe comprising: a probe body; at least one illuminating optical fiber that transmits light to a distal end thereof to illuminate a region of the surface and interact with the material; and at least one receiving optical fiber, positioned to receive light that has been transmitted by the illuminating fiber to the region and has interacted with the material, which received light is used for acquiring the measurements, the receiving fiber thereby being defined as associated with the illuminating fiber; wherein at least one of the fibers has a portion inside the probe body with a bend.
    Type: Application
    Filed: December 19, 2005
    Publication date: July 20, 2006
    Applicant: CritiSense, Ltd.
    Inventors: Eliahu Pewzner, Assaf Deutsch, Yoram Blum, Avraham Mayevsky
  • Publication number: 20050234315
    Abstract: An apparatus, system and method are provided for diagnosing the degree of body metabolic emergency state. A non-vital organ with respect to the metabolic emergency state is first chosen. One or more tissue viability parameters including at least one of NADH and Flavoprotein (Fp) concentration are monitored in the non-vital organ, whereupon the degree of body metabolic emergency state may be determined based on the monitored tissue viability parameters.
    Type: Application
    Filed: March 6, 2003
    Publication date: October 20, 2005
    Inventors: Avraham Mayevsky, Eliahu Pewzner, Assaf Deutsch, Tamar Manor
  • Publication number: 20050043606
    Abstract: Apparatus for monitoring a plurality of tissue viability parameters of a substantially identical tissue element, in which a single illumination laser source provides illumination radiation at a wavelength such as to enable monitoring of blood flow rate and NADH or flavoprotein concentration, together with blood volume and also blood oxygenation state. In preferred embodiments, an external cavity laser diode system is used to ensure that the laser operates in single mode or at else in two or three non-competing modes, each mode comprising a relatively narrow bandwidth. A laser stabilisation control system is provided to ensure long term operation of the laser source at the desired conditions.
    Type: Application
    Filed: September 25, 2001
    Publication date: February 24, 2005
    Inventors: Eliahu Pewzner, Avraham Mayevsky, Alexander Jaronkin, Igor Derzy
  • Publication number: 20040054270
    Abstract: Apparatus for monitoring a plurality of tissue viability parameters of a tissue layer element, in which two different illumination sources are used via a common illumination element in contact with the tissue. One illumination source is used for monitoring blood flow rate and optionally flavoprotein concentration, and collection fibers are provided to receive the appropriate radiation from the tissue. The other illuminating radiation is used for monitoring any one of and preferably all of NADH, blood volume and blood oxygenation state of the tissue element, and collection fibers are provided to receive the appropriate radiation from the tissue. In one embodiment, the wavelengths of the two illumination sources are similar, and common collection fibers for the two illuminating radiations are used. In another embodiment, the respective collection fibers are distanced from the illumination point at different distances correlated to the ratio of the first and second illuminating wavelengths.
    Type: Application
    Filed: March 25, 2003
    Publication date: March 18, 2004
    Inventors: Eliahu Pewzner, Avraham Mayevsky
  • Publication number: 20030152250
    Abstract: A personal identification instrument (PII) including a naked-eye-viewable image of a legitimate PII owner and an encoded image of said legitimate PII owner disposed on a substrate, wherein the naked-eye-viewable image and the encoded image comprise different aspects of the legitimate PII owner.
    Type: Application
    Filed: February 12, 2002
    Publication date: August 14, 2003
    Inventors: Eliahu Pewzner, Moshe zucker